Furthermore, the levels of ASPP2 and MiR-205 were inversely correlated with each other, suggesting MiR-205-mediated gene silencing may be one of major mechanisms to inhibit ASPP2 in vivo at least in cervical cancers (r2=0.55, P<0.01, Figure 1d). The gene discussed is TP53BP2; the disease is cervical carcinoma.